Refractory pneumothoraces with bronchopleural fistula (BPF) pose a significant challenge in managing critically sick and ventilated neonates. We report a case of the term female neonate being treated with extracorporeal membrane oxygenation (ECMO) support for meconium aspiration and presumed sepsis, with a significant air leak refractory to pleural drainage that was managed using endobronchial application of cyanoacrylate (enbucrilate) glue to seal the leak. (2013) 33, 659-660; doi:10.1038/jp.2012.159 Keywords: newborn; ECMO; bronchopleural fistula; cyanoacrylate glue BACKGROUND Acute lung conditions are common in neonatal intensive care units. Neonatal tension pneumothorax has been reported following the use of intubation bougies and airway instrumentation.
1
Bronchopleural fistula (BPF) and ensuing tension pneumothorax result from an abnormal airflow track between the tracheobronchial tree and pleural cavity. The immediate management of BPF is drainage of the pleural cavity with insertion of a chest drain. Once the drain is in place to assist lung expansion, further management of BPF includes persistent chest-drain management (with or without suction) and ventilatory strategies including high-frequency jet ventilation or selective ventilation of the contralateral lung. Various bronchoscopic and surgical interventions have been employed to control the fistula.
Cyanoacrylate glues are typically used for wound closure or arterial embolization. There are individual case reports demonstrating the efficacy of N-butyl-2-cyanoacrylate (enbucrilate) in adults with BPF, with minimal complications.
2 This is the first report of cyanoacrylate glue use via transbronchial approach to close BPF in a neonate.
CASE
A female infant (3730 g) was born at 40 þ 1 week's gestation by emergency cesarean section for failure to progress, meconiumstained liquor and suspicion of chorioamnionitis. She developed respiratory distress at 10 min, with oxygen saturation in 70 s. She was intubated and ventilated by 1 hour of age. She received one dose of poractant alfa (Curosurf, Dey Pharma, Palermo, Italy), inhaled nitric oxide (iNO) and maximum inotropic support before being transported by the ambulance team for extracorporeal membrane oxygenation (ECMO).
She was initially intubated with 3.5-mm-uncuffed endotracheal tube (ETT). This was exchanged for a 3.5-mm-cuffed ETT over a bougie by the neonatal transport team due to a large air leak. Respiratory and haemodynamic stability was lost at the time of ETT exchange, with loss of end-tidal CO 2 and SaO 2 traces and reduced air entry to the right lung. A chest radiograph showed tension pneumothorax that was treated with needle aspiration followed by insertion of an 8-French chest drain (CD).
At the time of transfer to our hospital on day 1 of life, her treatment included adrenaline (0.5 mg kg
) and sodium bicarbonate (6 mmol h
). There was a severe metabolic acidosis on arrival, with pH 7.1, PCO 2 3.5 kPa, PO 2 17 kPa, base excess À 20 mmol l À 1 and lactate 420 mmol l À 1 . There was persistence of large air leak from the right pleural space despite CD with applied suction. She showed initial haemodynamic improvement with ongoing iNO and high frequency oscillatory (HFO) ventilation support. Echocardiogram showed a structurally normal heart with right ventricular pressure 2/3 of systemic arterial pressure. She also had a large patent ductus arteriosus with a shunt predominantly from left to right.
Her clinical condition worsened over the next few hours with difficulty maintaining PaO 2 , and she commenced venoarterial ECMO at 22 h of age. Subsequently, the main concern was persistence of the right pneumothorax despite CD suction. She failed to wean off ECMO after 7 days, due to hypoxia secondary to persistence of the large right-sided air leak. A clinical diagnosis of BPF was made, and various management options were discussed. Surgical exploration to close the air leak or lobectomy, though feasible, could have resulted in catastrophic bleeding due to her anticoagulated state on ECMO.
A trans-bronchial approach was used to localize and close the fistula. The patient was taken to the interventional radiology suite for a flexible bronchoscopy. Selective bronchography was performed in each segmental bronchus using the non-ionic iodinated contrast agent iohexol (Omnipaque 240, Nycomed Imaging AS, Oslo, Norway) injected through a 5-French angled angiographic catheter (BMC, Cook Medical, Bjaeverskov, Denmark). This showed a BPF arising from a segmental bronchus in the right lower lobe (Figure 1) . A microcatheter (Magic 1.8, Balt, Montmorency, France) was advanced through the catheter and into the affected bronchus. The BPF was then closed by injecting 0.7 ml of a 9:1 mixture of enbucrilate (Histoacryl, B Braun Melsungen AG, Melsungen, Germany) and ethiodized oil (Lipiodol Ultra-fluide, Guerbet, Roissy, France) opacified with tantalum powder, using X-ray guidance.
Her repeated chest radiograph showed no re-accumulation of air, and she was successfully weaned off ECMO and decannulated. The CD was removed on the third post-procedural day (Figure 2) , and she was discharged for home breast feeding on day 22.
DISCUSSION
Air leaks in neonates may resolve spontaneously or require chest drain insertion. When CD fails, the most common management is by a surgical approach. 3 Non-surgical alternatives include transthoracic and bronchoscopic techniques. The simplest approach is to inject an appropriate substance through the chest tube (pleurodesis). 4 Various materials are available to inject. Medical grade talc slurry is most effective, but the accelerated inflammatory response and sometimes irregular pleural adhesion may result in loculated air accumulation in the event of failure. Fibrin glue is a biological tissue adhesive agent that consists of fibrinogen and factor XIII combined with thrombin and calcium to form a coagulum. This produces a fibrin clot within seconds. This technique has been used successfully to treat resistant pneumothorax in premature infants. In one of retrospective review of fibrin glue treatment via a pleural air pocket, six of the eight preterm infants had resolution of air leak within 24 h, with removal of the CD by a mean of 6 days. The complications reported were diaphragm paralysis, bradycardia, contralateral pneumothorax, necrosis and hypercalcemia. The authors concluded that fibrin glue should be reserved for patients with persistent pneumothorax, not responding to an adequate trial of conventional therapy.
Surgical treatments include open thoracotomy or thoracoscopy, though the latter approach may be limited by the size of the patient. Methods used to control BPF by surgery include oversewing, resection (both non-anatomical wedge and lobectomy), and use of topical sealants. Surgery in our patient was limited by ECMO, which makes control of intraoperative and postoperative bleeding very difficult. This prompted us to consider other means to control the BPF.
Transbronchial treatment of neonatal BPF is less commonly reported, 5 and ECMO is a relative but not absolute contraindication. We used bronchography to identify the site of the BPF, followed by a localized application of enbucrilate (cyanoacrylate glue) to eliminate the air leak, while minimizing injury to the surrounding lung tissues. This technique is minimally invasive, could be repeated if unsuccessful and can be performed during ECMO. The main disadvantages are that it needs familiarity with the glue injection technique, may cause thermal injury to adjacent lung (polymerization of glue is exothermic), and that reflux of enbucrilate may cause excessive bronchial occlusion.
To conclude, the transbronchial approach may be effective in controlling BPF and can be repeated if it fails on initial application. It is minimally invasive, and can be performed in extreme situations such as during extracorporeal support. Thermal injuries to adjacent lung or spill of glue into adjacent bronchi are potential complications. More experience is needed before this becomes a routine approach. 
